Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Long-Term Deferred Tax (2016 - 2023)

Biomerica's Long-Term Deferred Tax history spans 11 years, with the latest figure at $8.1 million for Q1 2023.

  • Quarterly results put Long-Term Deferred Tax at $8.1 million for Q1 2023, changed N/A from a year ago — trailing twelve months through Feb 2023 was $8.1 million (changed N/A YoY), and the annual figure for FY2022 was $7.0 million, changed.
  • Long-Term Deferred Tax for Q1 2023 was $8.1 million at Biomerica, up from $7.7 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $8.1 million in Q1 2023 to a low of $10000.0 in Q1 2019.
  • The 3-year median for Long-Term Deferred Tax is $7.4 million (2022), against an average of $6.0 million.